Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Omar Nadeem, Md

Clinical trials sponsored by Omar Nadeem, Md, explained in plain language.

Trials to join now! 1 Not yet finished but already full! 1

New drug combo aims to extend remission for Tough-to-Treat blood cancer

Disease control Recruiting now

This study is testing whether a combination of three drugs (elotuzumab, iberdomide, and dexamethasone) can help keep multiple myeloma in remission for longer after patients receive a specialized cell therapy called ide-cel (CAR-T). The goal is to prevent or delay the cancer from …

Phase: PHASE1, PHASE2 • Sponsor: Omar Nadeem, MD • Aim: Disease control

Last updated Apr 02, 2026 14:57 UTC